Quest Diagnostics Total Liabilities and Share Holders Equity 2010-2024 | DGX
Quest Diagnostics total liabilities and share holders equity for the quarter ending September 30, 2024 was $16.095B, a 19.38% increase year-over-year.
- Quest Diagnostics total liabilities and share holders equity for 2023 was $14.022B, a 9.23% increase from 2022.
- Quest Diagnostics total liabilities and share holders equity for 2022 was $12.837B, a 5.69% decline from 2021.
- Quest Diagnostics total liabilities and share holders equity for 2021 was $13.611B, a 2.96% decline from 2020.